UBS Rolls Out Buy-Side Research

The New York arm of Swiss financial services firm UBS is introducing a curious animal into stock research: internally generated buy-side research that competes with the firm's own sell-side research. The brokerage firm is assembling a group of 10 to 20 analysts who will compile stock recommendations, ostensibly intended to supplement the recommendations put together by the firm's existing staff of sell-side analysts. In putting together their recommendations, the new group would be at liberty to consult research conducted by other Wall Street firms.

» UBS Embraces the Buy Side TheStreet.com